Anurag Shukla

Title: Anurag Shukla: Innovator in Pharmaceutical Chemistry

Introduction

Anurag Shukla is a notable inventor based in Pune, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds for treating serious diseases. His work has led to the filing of multiple patents, showcasing his innovative approach to solving complex health issues.

Latest Patents

Anurag Shukla holds 2 patents that focus on silicon-based cyclic compounds and their pharmaceutical applications. His first patent involves silicon incorporated cyclic compounds designed for treating malaria and toxoplasmosis. This invention discloses novel compounds that include various aryl groups and inorganic or organic anions, providing a new avenue for therapeutic interventions. The second patent details silicon incorporated quinolines with anti-malarial and anti-toxoplasmosis activity. This invention outlines a process for preparing these quinolines and their use in pharmaceutical compositions, offering potential treatments for diseases caused by coccidian parasites.

Career Highlights

Anurag Shukla is affiliated with the Council of Scientific and Industrial Research, where he continues to advance his research in pharmaceutical chemistry. His work is characterized by a commitment to innovation and a focus on developing effective treatments for infectious diseases.

Collaborations

Anurag has collaborated with notable colleagues, including Remya Ramesh and Dumbala Srinivasa Reddy. These partnerships have contributed to the success of his research and the development of his patented inventions.

Conclusion

Anurag Shukla's contributions to pharmaceutical chemistry through his innovative patents highlight his role as a key inventor in the field. His work not only addresses critical health challenges but also paves the way for future advancements in medical treatments.